Difficulty: Medium
Average Score: 87%
Practice
A client is receiving terbutaline (Brethine) IV for preterm labor. Which of the following maternal findings would warrant stopping the infusion?
Correct answer
A
Rationale
In the case of a client receiving terbutaline (Brethine) IV for preterm labor, the correct answer warranting stopping the infusion is option A) Cardiac arrhythmias. Terbutaline is a beta-2 adrenergic agonist that can potentially lead to adverse cardiac effects such as tachycardia, palpitations, and arrhythmias. These effects can be exacerbated in the IV route due to the rapid onset of action.
Option B) Respiratory rate of 24 rpm is within normal limits and not a direct contraindication for stopping the infusion. Option C) Blood pressure of 90/60 is low but not an immediate concern unless accompanied by symptoms of shock. Option D) Hypocalcemia is not a common adverse effect of terbutaline and would not be a primary reason to stop the infusion.
Educationally, this question highlights the importance of monitoring maternal responses to medications during pregnancy, especially those used to manage preterm labor. Understanding the potential side effects and contraindications of medications like terbutaline is crucial for providing safe and effective care to pregnant clients. Vigilant assessment and prompt intervention based on assessment findings are essential in managing maternal and fetal well-being during pregnancy.
Option B) Respiratory rate of 24 rpm is within normal limits and not a direct contraindication for stopping the infusion. Option C) Blood pressure of 90/60 is low but not an immediate concern unless accompanied by symptoms of shock. Option D) Hypocalcemia is not a common adverse effect of terbutaline and would not be a primary reason to stop the infusion.
Educationally, this question highlights the importance of monitoring maternal responses to medications during pregnancy, especially those used to manage preterm labor. Understanding the potential side effects and contraindications of medications like terbutaline is crucial for providing safe and effective care to pregnant clients. Vigilant assessment and prompt intervention based on assessment findings are essential in managing maternal and fetal well-being during pregnancy.